The post Well Equipped Research Laboratory appeared first on Orchev Pharma PVT. LTD.

The post Launch of Additional APIs appeared first on Orchev Pharma PVT. LTD.

The post Globally Approved Facility appeared first on Orchev Pharma PVT. LTD.

Since the beginning of operations in 1989, Orchev Pharma Pvt. Ltd. has quickly emerged as a leading manufacturer of high-quality pharmaceutical raw material in the Gujarat State of India. What separates Orchev from other trusted manufacturers is not only that we manufacture excellent quality APIs and intermediates; provide excellent services to customers, which additionally includes small scale manufacturing of product for trial supply and full-scale manufacturing for commercial supply. Orchev employs chemists, chemical engineers, microbiologists of the highest caliber and maintains the quality assurance standard.

With the aim to manufacture high-quality Ranitidine, Famotidine, Telmisartan, and Levetiracetam, our organization has believed in continuous development and evaluation.

With our proven experience and expertise; Orchev manufactures under (fully complies with) the standards of USFDA, CEP and WHO-GMP. We have been audited & Approved by EDQM, AEMPS(Spain), Korean Food and Drug Administration (KFDA), and COFEPRIS – Mexican Health Authority.  Orchev Pharma Pvt. Ltd. is an ISO 9001:2015 company.  In August 2018, the USFDA inspected our manufacturing facility which was cleared with ZERO 483.

What’s new:

2023 a year of Events for API – Famotidine:

• ORCHEV’s US-DMF#036764 for Famotidine passed CA and the customer received approval of ANDA in October 2023.
• Received CEP 2022-307 for Famotidine in August 2023 from EDQM.
• Chinese DMF # Y20220000306 for Famotidine registration successful with IDL Status “A” in December 2023.

The post Homepage appeared first on Orchev Pharma PVT. LTD.